Reprogramming human T cell function and specificity with non-viral genome targeting
暂无分享,去创建一个
Jonathan S. Weissman | Alan Ashworth | Antoni Ribas | Stephen H. Hughes | Eric Shifrut | Amy L. Putnam | Jonathan H. Esensten | Manuel D. Leonetti | Kevan C. Herold | Channabasavaiah B. Gurumurthy | Rolen M. Quadros | Rosa Bacchetta | Michael Haugwitz | Gorka Alkorta-Aranburu | Cristina Puig-Saus | Hiroyuki Matsumoto | David Carmody | Alexander Marson | A. Ashworth | J. Weissman | M. Leonetti | A. Ribas | E. Meffre | A. Marson | Eric Shifrut | J. Hiatt | Theodore L. Roth | K. Herold | M. Roncarolo | G. Alkorta-Aranburu | Y. Mao | A. Ferris | Montse Morell | S. Greeley | D. del Gaudio | Andy P May | J. Carnevale | Victoria R. Tobin | A. Putnam | Kathrin Schumann | R. Bacchetta | Justin D. Saco | C. Puig-Saus | D. Carmody | Maria Grazia Roncarolo | Paige Krystofinski | Jeff W. Chen | J. Schickel | N. Romberg | Michael R. Lee | M. Haugwitz | Andrew P. May | Eric Meffre | Justin Saco | Montse Morell | Joseph Hiatt | Andrea L. Ferris | Kathrin Schumann | Han Li | Ruby Yu | David N. Nguyen | Gary M. Kupfer | Han Li | Ruby Yu | Julia Carnevale | P. Jonathan Li | Victoria Tobin | Jean-Nicolas Schickel | Laurence Pellerin | Daniela Del Gaudio | Ying Mao | Min Cho | Baz Smith | Siri Atma W. Greeley | Neil Romberg | Paige Krystofinski | Laurence Pellerin | Hiroyuki Matsumoto | Baz Smith | C. Gurumurthy | R. Quadros | M. Cho | P. J. Li | S. Hughes | Gary Kupfer | Gary M. Kupfer
[1] F. Cosset,et al. Lentiviral vector gene transfer into human T cells. , 2009, Methods in molecular biology.
[2] Sruthi Mantri,et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells , 2016, Nature.
[3] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[4] Claudio Mussolino,et al. Refining strategies to translate genome editing to the clinic , 2017, Nature Medicine.
[5] S. Warming,et al. Efficient mapping of transgene integration sites and local structural changes in Cre transgenic mice using targeted locus amplification , 2017, Nucleic acids research.
[6] H. Dadi,et al. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor , 1997 .
[7] Bent K. Jakobsen,et al. Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions , 2008, The Journal of Immunology.
[8] S. Rosenberg,et al. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] Andreas Reinisch,et al. Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6 , 2017, eLife.
[10] Graham Dellaire,et al. Marker-free coselection for CRISPR-driven genome editing in human cells , 2017, Nature Methods.
[11] Jennifer A. Doudna,et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins , 2015, Proceedings of the National Academy of Sciences.
[12] J. Murnane,et al. Recombination events during integration of transfected DNA into normal human cells. , 1990, Nucleic acids research.
[13] S. Henikoff,et al. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites , 2016, bioRxiv.
[14] V. Hornung,et al. Intracellular DNA recognition , 2010, Nature Reviews Immunology.
[15] Bo Huang,et al. A scalable strategy for high-throughput GFP tagging of endogenous human proteins , 2016, Proceedings of the National Academy of Sciences.
[16] A. Scharenberg,et al. Therapeutic Gene Editing Safety and Specificity. , 2017, Hematology/oncology clinics of North America.
[17] Edward M. Callaway,et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration , 2016, Nature.
[18] W. Lim,et al. The Principles of Engineering Immune Cells to Treat Cancer , 2017, Cell.
[19] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[20] Mithat Gönen,et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection , 2017, Nature.
[21] Howard Y. Chang,et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation , 2017, Nature.
[22] Yutaka Inagaki,et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins , 2017, Genome Biology.
[23] A. Scharenberg,et al. Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells , 2017, Molecular therapy. Methods & clinical development.
[24] S. Rosenberg,et al. Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.
[25] Jonathan S. Weissman,et al. Design and specificity of long ssDNA donors for CRISPR-based knock-in , 2017, bioRxiv.
[26] Daesik Kim,et al. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins , 2014, Genome research.
[27] M. Daly,et al. Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.
[28] Michel Sadelain,et al. Therapeutic T cell engineering , 2017, Nature.
[29] G. Church,et al. Cas9 as a versatile tool for engineering biology , 2013, Nature Methods.